Previous Close | 9.50 |
Open | 9.45 |
Bid | 10.30 |
Ask | 10.55 |
Strike | 130.00 |
Expire Date | 2024-10-18 |
Day's Range | 9.45 - 9.45 |
Contract Range | N/A |
Volume | |
Open Interest | 321 |
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) ...
Moderna stock is on the rise again as investors focus on the potential need for a bird flu vaccine. Is MRNA stock a buy right now?